Error 404 - Not Found

Suggestions

Heparin Investigation Baxter Healthcare Corporation by Zoll and Kranz On February 14, 2008, Zoll, Kranz & Borgess, LLC was the first law firm in the nation to file suit against Baxter Healthcare Corporation and other related

Baxter U.S. - Safety Information: Heparin Sodium Injection Baxter is continuing its investigation to understand how and why this contaminant was introduced into the heparin supply chain. In the meantime, Baxter will

FINAL 03-05 investigation update File Format: PDF/Adobe Acrobat - Quick View FDA and Baxter concluded that it was better for public health to allow the Baxter multi- Investigation of Adverse Event Reports Associated with Heparin

FDA's Ongoing Heparin Investigation ONGOING FDA HEPARIN INVESTIGATION Brief Overview. Beginning in January 2008, Baxter Healthcare Corporation (Baxter) recalled various lots of heparin ,

Baxter Announces Findings From Premix Heparin IV Bag Investigation Today, Baxter is announcing that its investigation of reports from Beebe Medical Center has determined that the three patient events are unrelated to

Baxter Heparin Contamination » Nolan Law Group February 14, 2008: FDA investigations reveal information about inadequate testing and supply-chain issues associated with the Baxter Heparin .

Medical News: Heparin -Like Contaminant Found in Recalled Baxter At a briefing that followed the FDA press conference, Baxter Healthcare confirmed the FDA report Baxter Recalls Heparin as FDA Investigation Continues

Heparin - Voluntary Recall of Baxter 1000 unit/mL, 5000 unit/mL The FDA's investigations found a heparin -like contaminant in active In February 2008, Baxter Healthcare voluntarily recalled all single-dose and

Heparin Blood Thinner Recall Lawsuit Attorneys in Los Angeles CA If you or a loved one has been treated with Baxter Int. heparin and suffered severe Initial Baxter International investigations suggest that a "fake

Heparin Lawsuits Transferred Heparin syringes Heparin injection The lawsuits name Baxter Healthcare Corp as a defendant along with a Chinese supplier. Heparin was recalled in January after the drug was found to be